BD, a leading global medical technology company, will introduce its latest advancement in end-to-end IV safety, the new BD Cato™ ReadyMed solution — a digital solution that integrates with BD Cato, designed to help hospitals optimize the IV chemotherapy administration process by simplifying workflows and providing medication visibility with the ability to track the medication’s journey to the patient.
↧